CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.

Autor: Kanamori, Koichiro1,2 (AUTHOR), Suina, Kentaro1,2 (AUTHOR), Shukuya, Takehito1,2 (AUTHOR) tshukuya@juntendo.ac.jp, Takahashi, Fumiyuki1,2 (AUTHOR), Hayashi, Takuo3 (AUTHOR), Hara, Kieko3 (AUTHOR), Saito, Tsuyoshi3 (AUTHOR), Mitsuishi, Yoichiro1,2 (AUTHOR), Shimamura, Shoko Sonobe1,2 (AUTHOR), Winardi, Wira1,2 (AUTHOR), Tajima, Ken1,2 (AUTHOR), Ko, Ryo1,2 (AUTHOR), Mimori, Tomoyasu1,2 (AUTHOR), Asao, Tetsuhiko1,2 (AUTHOR), Itoh, Masayoshi4,5 (AUTHOR), Kawaji, Hideya4,6,7 (AUTHOR), Suehara, Yoshiyuki8 (AUTHOR), Takamochi, Kazuya9 (AUTHOR), Suzuki, Kenji9 (AUTHOR), Takahashi, Kazuhisa1,2 (AUTHOR)
Zdroj: Thoracic Cancer. Apr2023, Vol. 14 Issue 12, p1089-1097. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje